High-dose TXA more effective than low-dose TXA and placebo for reducing blood loss in PLIF
The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized studyEur Spine J. 2017 Nov;26(11):2851-2857
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
72 patients scheduled for posterior lumbar interbody fusion were randomized to either high-dose tranexamic acid, low-dose tranexamic acid, or placebo saline. All patients were treated with an initial bolus prior to incision, followed by continuous infusion for the next 5 hours. Main outcome measures included intraoperative, postoperative, and total blood loss, as well as transfusion rate. Measures...
Join the Conversation
Please Login or Join to leave comments.